Clinical Trial Update: A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 1]

View source ↗

Summary

This clinical trial update reports termination of a Phase 1 study of ALN-HSD in healthy adult subjects and adults with nonalcoholic steatohepatitis (NASH).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• ALN-HSD

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Nonalcoholic Steatohepatitis, NASH | Phase 1 | Status: TERMINATED